Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders

被引:0
|
作者
R. Krüger
T. Müller
O. Riess
机构
[1] Department of Neurology,
[2] St. Josef-Hospital,undefined
[3] Ruhr-University,undefined
[4] Bochum,undefined
[5] Department of Medical Genetics,undefined
[6] Children's Hospital,undefined
[7] University Rostock,undefined
[8] Rostock,undefined
[9] Federal Republic of Germany,undefined
来源
Journal of Neural Transmission | 2000年 / 107卷
关键词
Keywords: Alzheimer's disease, α-synuclein, neurodegeneration, Parkinson's disease.;
D O I
暂无
中图分类号
学科分类号
摘要
A major step in the elucidation of the pathogenesis of neurodegenerative disorders was the identification of a mutation in the α-synuclein gene in autosomal dominant Parkinson's disease (PD). α-Synuclein is the main component of Lewy bodies (LB), the neuropathological hallmark of PD. Moreover, a fragment of α-synuclein (NAC) is the second major component of amyloid plaques in Alzheimer's disease (AD). Recent studies of other neurodegenerative disorders such as dementia with LB (DLB), multiple system atrophy (MSA) and amyotrophic lateral sclerosis (ALS) also revealed intracellular accumulations of α-synuclein in affected brain regions. This may indicate that these disorders partially share common pathogenic mechanisms. Recent data provide first insights into the physiological function of α-synuclein and support the concept of an essential role of α-synuclein in neurodegeneration. Increasing knowledge on the pathogenic molecular mechanisms of neurodegeneration and of the pathophysiological function of α-synuclein in particular may influence future development of therapeutic strategies in neurodegenerative disorders.
引用
收藏
页码:31 / 40
页数:9
相关论文
共 50 条
  • [21] Melatonin in Alzheimer's disease and other neurodegenerative disorders
    Srinivasan V.
    Pandi-Perumal S.R.
    Cardinali D.P.
    Poeggeler B.
    Hardeland R.
    Behavioral and Brain Functions, 2 (1)
  • [22] α-Synuclein: A Promising Biomarker for Parkinson's Disease and Related Disorders
    Hatano, Taku
    Okuzumi, Ayami
    Matsumoto, Gen
    Tsunemi, Taiji
    Hattori, Nobutaka
    JOURNAL OF MOVEMENT DISORDERS, 2024, 17 (02) : 127 - 137
  • [23] α-synuclein and Parkinson's disease:: Selective neurodegenerative effect of α-synuclein fragment on dopaminergic neurons in vitro and in vivo
    Forloni, G
    Bertani, I
    Calella, AM
    Thaler, F
    Invernizzi, R
    ANNALS OF NEUROLOGY, 2000, 47 (05) : 632 - 640
  • [24] Alpha-Synuclein Pathophysiology in Neurodegenerative Disorders: A Review Focusing on Molecular Mechanisms and Treatment Advances in Parkinson's Disease
    Yaribash, Shakila
    Mohammadi, Keyhan
    Sani, Mahmood Alizadeh
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2025, 45 (01)
  • [25] S-nitrosylation in Parkinson's disease and related neurodegenerative disorders
    Chung, KKK
    Dawson, VL
    Dawson, TM
    NITRIC OXIDE, PT E, 2005, 396 : 139 - 150
  • [26] Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders
    Lindstrom, Veronica
    Ihse, Elisabet
    Fagerqvist, Therese
    Bergstrom, Joakim
    Nordstrom, Eva
    Moller, Christer
    Lannfelt, Lars
    Ingelsson, Martin
    IMMUNOTHERAPY, 2014, 6 (02) : 141 - 153
  • [27] The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders
    Koichi Wakabayashi
    Kunikazu Tanji
    Saori Odagiri
    Yasuo Miki
    Fumiaki Mori
    Hitoshi Takahashi
    Molecular Neurobiology, 2013, 47 : 495 - 508
  • [28] Parkinson's disease and tauopathies: Neurodegenerative protein misfolding disorders
    Trojanowski, JQ
    MOVEMENT DISORDERS, 2006, 21 : S5 - S5
  • [29] Neurotrophic factors in neurodegenerative disorders: Model of parkinson's disease
    Garcia de Yebenes, Justo
    Angeles Mena, Maria
    NEUROTOXICITY RESEARCH, 2000, 2 (2-3) : 115 - 137
  • [30] Neurotrophic factors in neurodegenerative disorders: Model of parkinson’s disease
    Justo Garcia de Yebenes
    Maria Angeles Mena
    Neurotoxicity Research, 2000, 2 : 115 - 137